1、该刊只有国际刊号！

2、投稿方式：在线投稿。

3、官网网址：

https://www.sciepublish.com/journals/gct

4、投稿系统：

https://www.sciepublish.com/index/user/login.html

5、主办单位官网（湖北三峡实验室）：

https://www.hbsxsys.com/

6、官网邮箱：gct@sciepublish.org

7、出刊日期：季刊，一年出版4期。

8、官网信息：2026年12月31日前无需支付文章处理费(APC)

2026年1月30日星期五

Guide for Authors

【官网信息】

1. Before Submission

Before you submit to Green Chemical Technology, please go through the following information carefully.

1.1. Submission Checklist

Please:

read the Aims & Scope to check if your manuscript is suitable for this journal;

use the Microsoft Word template to prepare your manuscript; If you prefer to prepare references with bibliography software, download the EndNote Style;

make sure that issues about research and publication ethics, conflicts of interest, author contributions, data and materials availability, and funding have been clarified appropriately;

ensure that all authors have approved the content of the submitted manuscript;

all manuscripts must be submitted online through SCIEPublish manuscript platform.

1.2. Open Access, License and Copyright

Green Chemical Technology is a peer-reviewed, fully open access journal. All articles published with open access will be immediately and permanently free for everyone to read, download, copy, and distribute as defined by Creative Commons CC BY 4.0 license. Copyright is retained by authors.

1.3. Article Charge Processing (APC)

There is no article processing charge (APC) for authors publishing in Green Chemical Technology before 31 December 2025. There are no additional charges based on color, length, figures, or other items.

2. Submission Preparation

2.1. Types of Article

Manuscripts submitted to Green Chemical Technology should neither be published previously nor be under consideration for publication in another journal. The main article types are as follows:

Original Research Article (5000-10000 words): Original research manuscript reports scientifically sound experiments and provides a substantial amount of new information with enough related tables and/or figures and a clear structure to contain Introduction, Material and Methods, Results, Discussion and Conclusions.

Review paper (5000-15000 words): Review should provide a complete and balanced overview on the latest progress in a given area of research.

Communication (2000-5000 words): Communication is a short research article usually claiming certain results, which present original and significant material for rapid dissemination.

Case Report (2000-5000 words): Case report usually describes an unusual or novel occurrence and as such, remain one of the cornerstones of medical progress and provide many new ideas in medicine.

Other article types often invited by Editors are also considered, such as Editorial, Perspective, Commentary, Opinion, Letter to Editor, and so on. Details can be found at For Authors.

2.2. Article Structure

2.2.1. Title Page

Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.

Author names and affiliations. Please clearly indicate the given name(s) and family name(s) of each author and check that all names are accurately spelled. You can add your name between parentheses in your own script behind the English transliteration. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author.

Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. This responsibility includes answering any future queries about Methodology and Materials. Ensure that the e-mail address is given and that contact details are kept up to date by the corresponding author.

Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a "Present address" (or "Permanent address") may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.

Publication history. The submission date, revised date, and accepted date will be included in this part.

Abstract. A concise and structured abstract is required. The abstract should state briefly the purpose of the research, the main methods or treatments applied, the principal results and major conclusions. The abstract should be an objective representation of the article and it must not contain results that are not presented and substantiated in the main text and should not exaggerate the main conclusions. An abstract is often presented separately from the article, so it must be able to stand alone. For this reason, References should be avoided. Also, non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself. A single paragraph of about 200 words maximum.

Graphical abstract. The graphical abstract is optional, but it draws more attention to the online article. The graphical abstract should summarize the contents of the article in a concise, pictorial form designed to capture the attention of a wide readership. Graphical abstract should be submitted as a separate file in the online submission system. Image size: Please provide an image with a minimum of 374 × 990 pixels (h × w) and high resolution of 300 dpi. Preferred file types: TIFF, PNG or MS Office files.

Keywords. provide a maximum of 8 keywords, avoiding general and plural terms and multiple concepts.

Copyright. Authors retain copyright of their works through Creative Commons CC BY 4.0 license that clearly states how readers can copy, distribute, and use their attributed research, free of charge. A declaration "©The Author(s) Year." will be added to each article.

2.2.2. Main text

Introduction. State the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a summary of the results.

Material and Methods. Provide sufficient details to allow the work to be reproduced by an independent researcher. Methods that are already published should be summarized, and indicated by a reference. If quoting directly from a previously published method, use quotation marks and also cite the source. Any modifications to existing methods should also be described.

Results. Results should be clear and concise. Each Figure, Table, Scheme and supplementary information with a short and concise caption should be inserted into the main text close to their first citation and must be numbered following their number of appearance (Figure 1, Scheme I, Table 1, etc.).

Discussion. This should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive citations and discussion of published literature.

Conclusions. The main conclusions of the study may be presented in a short Conclusions section, which may stand alone or form a subsection of a Discussion or Results and Discussion section.

2.2.3. Back Matter

Supplementary. This refers to the supporting information, such as additional images, data, audios or videos. They should be cited in the main text in numeric order (e.g., Figure S1, Figure S2, Table S1, Table S2, Video S1, etc.). The style of supplementary figures or tables should be the same requirements as figures or tables in main text. Videos and audios should be prepared in English, and limited to a size of 500 MB. It will be named as Figure S1: title; Table S1: title; Video S1: title, etc.

Appendices. If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc. Similarly for tables and figures: Table A.1; Fig. A.1, etc.

Acknowledgments. The acknowledgement section can be used to thank anyone important in the publication of the work who does not qualify for authorship. This may include administrative and technical support, or donations in kind (e.g., materials used for experiments).

Author Contributions. For research articles with several authors, a short paragraph specifying their individual contributions must be provided. The following statements should be used "Conceptualization, X.X. and Y.Y.; Methodology, X.X.; Software, X.X.; Validation, X.X., Y.Y. and Z.Z.; Formal Analysis, X.X.; Investigation, X.X.; Resources, X.X.; Data Curation, X.X.; Writing – Original Draft Preparation, X.X.; Writing – Review & Editing, X.X.; Visualization, X.X.; Supervision, X.X.; Project Administration, X.X.; Funding Acquisition, Y.Y.”, please turn to the CRediT taxonomy for the term explanation.

Ethics Statement. Interventionary studies involving animals or humans, and other studies that require ethical approval, must list the authority that provided approval and the corresponding ethical approval code in this section. Please add “The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board (or Ethics Committee) of NAME OF INSTITUTE (protocol code XXX and date of approval).” OR “Ethical review and approval were waived for this study, due to REASON (please provide a detailed justification).” OR “Not applicable” for studies not involving humans or animals.

Informed Consent Statement. Any research article describing a study involving humans should contain this statement. Please add “Informed consent was obtained from all subjects involved in the study.” OR “Patient consent was waived due to REASON (please provide a detailed justification).” OR “Not applicable” for studies not involving humans.

Data Availability Statement. The statement is required for all original articles which informs readers about the accessibility of research data linked to a paper and outlines the terms under which the data can be obtained.

Funding. All sources of funding of the study should be disclosed. Please add: “This research received no external funding” or “This research was funded by [name of funder] grant number [xxx]” and “The APC was funded by [XXX]” in this section. Check carefully that the details given are accurate and use the standard spelling of funding agency names at https://search.crossref.org/funding, any errors may affect your future funding.

Declaration of Competing Interest. All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. If there are no interests to declare, please use the sentence: “The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper”

References. References must be numbered in order of appearance in the text (including citations in tables and legends) and listed individually at the end of the manuscript. In the text, reference numbers should be placed as [XX]. If there are 6 or less authors in one reference, please list all authors’ names in the Reference part. If there are more than 6 authors for one reference, please use “et al.” following the sixth author’s name.

2.3. Reference Formatting

Reference to a journal publication:

Author 1 AB, Author 2 CD. Title of the article. Abbreviated Journal Name Year, Volume, page range.

Reference to a book:

Author 1 A, Author 2 B. Book Title, 3rd ed.; Publisher: Publisher Location, Country, 2008; pp. 154–196.

Reference to a chapter in an edited book:

Author 1 A, Author 2 B. Title of the chapter. In Book Title, 2nd ed.; Editor 1 A, Editor 2 B, Eds.; Publisher: Publisher Location, Country, 2007; Volume 3, pp. 154–196.

Reference to an unpublished work:

Author 1 AB, Author 2 C. Title of Unpublished Work. Abbreviated Journal Name year, phrase indicating stage of publication (submitted; accepted; in press).

Reference to a patent:

Patent Owner 1; Patent Owner 2; et al. Title of Patent. Patent Number, Date (Day Month Year, the Application granted date).

Reference to a conference report/abstract:

Author 1 AB, Author 2 CD, Author 3 EF. Title of Presentation. In Proceedings of the Name of the Conference, Location of Conference, Country, Date of Conference (Day Month Year).

Reference to a thesis:

Author 1 AB. Title of Thesis. Level of Thesis, Degree-Granting University, Location of University, Country, Date of Completion.

Reference to website information:

Title of Site. Available online: URL (accessed on Day Month Year).

Journal abbreviations can be referred to the List of Title Word Abbreviations.

2.4. Images and Tables Formatting

Figures should be placed near to the first appearance in the main text. The corresponding caption should be placed directly below the figure. All symbols and abbreviations used in the images should be explained in the caption. The acceptable format is JPEG, PNG, or TIFF with a high resolution at least 300 dpi.

Tables should be inserted as editable format, not as images. It also should be near to the first appearance in the main text. The corresponding caption should be placed directly above the table, and footnotes below the table.

2.5. Others

Manuscript files can be in DOC and DOCX formats, and LaTex as well.

Abbreviations should be defined upon first appearance in the title, abstract, main text, heading/subheading and figure/table captions and used consistently thereafter.

General italic words include vs., et al., etc., i.e., in vivo, in vitro; t test, F test, U test; related coefficient as r/R2, sample number as n/N, and probability as p/P; names of genes; names of bacteria and biology species in Latin. All italic letters should be consistent in the manuscript.

Units should be abided by the International System of Units, such as h for hours, min for minutes, s for seconds. There is a space between the number and the unit (i.e., 5 mL), except for degree (°), solidus (/), and percent (%).

Numbers should be written as Arabic numerals. More than 4-Digit Numbers should be separated by comma, such as 12,345. Decimal notation should be converted scientific notation, such as 0.0001 for 1 × 10−4.

3. Authorship

Authorship should only be granted to those who have made substantial contributions to a published study that meet the four requirements outlined below:

Substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data for the work;

Drafting the work or revising it critically for important intellectual content;

Final approval of the version to be submitted;

Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

All those who meet these criteria should be identified as co-authors. Co-authors must specify their contributions in the section “Authors Contributions” of their manuscripts. Contributors who do not meet all four criteria (like being only involved in the acquisition of funding, general supervision of a research group, general administrative support, writing assistance, technical editing, language editing, proofreading, etc.) should be acknowledged in the section “Acknowledgements” in the manuscript rather than being listed as co-authors.

If a large multiple-author group has conducted the work, the group ideally should decide who will be co-authors before the work starts and confirm co-authors before submission. All researchers in the group named as co-authors must meet all four criteria for authorship.

The corresponding author (as least one member), usually a senior and experienced member of the submitted group or team), is responsible for:

communication with editors about submission, peer review, revision, proofreading, etc.;

ensuring all data and contents of the manuscript with co-authors' agreement;

confirming all co-authors to agree all matters comply with the policies of the journal;

being available for any post-publication queries.

SCIEPublish encourages all co-authors to provide ORCID IDs to improve transparency and unambiguous attribution of scholarly contributions.

In accordance with COPE guidance, AI and AI-assisted technologies/tools should not be listed as an author of a paper.

Changes to Authorship

Changes to the authorship, such as the addition, deletion, or sequence re-arrangement of co-authors, must be approved by every co-author and inform the editor of the change and co-authors' approval. After acceptance of a manuscript, those above changes to authorship are not permitted.

Author name changes

If an author requests to change their name after publication, the Editorial Office will consider such requirements under reasonable circumstances. The Editorial Office will strictly follow the COPE guidelines (How to handle authorship disputes: a guide for new researchers) to handle it and respect the author's request, but at the same time ensure that the published articles have transparent and reliable records.

Deceased authors

For cases in which a co-author dies during the writing, submission, or peer-review process, and the co-authors feel it is appropriate to include the author, co-authors should obtain approval from a (legal) representative which could be a direct relative.

更多详情：

https://www.sciepublish.com/journals/gct/instructions